Cargando…

MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway

This study aimed to investigate the interaction between miR-1278 and Caldesmon (CALD1) in gastric cancer (GC) and the regulatory mechanism. In both GC cells and tissues, the levels of CALD1, miR-1278, migration-related markers (E-cadherin, N-cadherin, and Snail), and MAPK signaling pathway-related p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jia-Bei, Zhang, Hao, Li, Xiao-Fang, Han, Shuang-Yin, Li, Xiu-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656762/ https://www.ncbi.nlm.nih.gov/pubmed/38025524 http://dx.doi.org/10.1515/med-2023-0776

Ejemplares similares

Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR‐1278
por: Wang, Xue, et al.
Publicado: (2022)

miR-335-5p suppresses gastric cancer progression by targeting MAPK10
por: Gao, Yi, et al.
Publicado: (2021)

MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing
por: Zhang, Sheng, et al.
Publicado: (2022)

CircPTK2 (hsa_circ_0003221) Contributes to Laryngeal Squamous Cell Carcinoma by the miR-1278/YAP1 Axis
por: Yang, Zhendong, et al.
Publicado: (2021)

CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Liu, Yixuan, et al.
Publicado: (2021)

Circ_0000190 suppresses gastric cancer progression potentially via inhibiting miR-1252/PAK3 pathway
por: Wang, Gui-Jun, et al.
Publicado: (2020)

Exploring emotional and social competencies in undergraduate students: Perspectives from CALD and non-CALD students
por: Yu, Mong-Lin, et al.
Publicado: (2022)

Oral Health Inequities among CALD and Non-CALD Older Australians: A Decomposition Analysis
por: Jamieson, Lisa, et al.
Publicado: (2023)

CALD1 Modulates Gliomas Progression via Facilitating Tumor Angiogenesis
por: Cheng, Quan, et al.
Publicado: (2021)

Role of the Long Intergenic Non-Protein-Coding RNA 1278/miR-185-5p/Cystatin SN Axis in Laryngeal Cancer Cells
por: Shen, Bin, et al.
Publicado: (2022)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2016)

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2017)

Role of miR-647 in human gastric cancer suppression
por: Cao, Wenlong, et al.
Publicado: (2017)

circ0101675 promotes malignant process via sponging miR-1278 and upregulating WNT3A/5A in non-small cell lung cancer
por: Du, Wei, et al.
Publicado: (2021)

MiR-877 suppresses gastric cancer progression by downregulating AQP3
por: Zhu, Hongyu, et al.
Publicado: (2020)

MiR-1284 suppresses gastric cancer progression by targeting EIF4A1
por: Wei, Weiyuan, et al.
Publicado: (2019)

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression
por: Yan, Jing, et al.
Publicado: (2016)

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2018)

MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015)

Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells
por: Xie, Gengchen, et al.
Publicado: (2017)

The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2018)

Echinacoside Suppresses the Progression of Breast Cancer by Downregulating the Expression of miR-4306 and miR-4508
por: Bian, Peng, et al.
Publicado: (2021)

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
por: Wei, Shuang, et al.
Publicado: (2019)

Response of Rhodococcus cerastii IEGM 1278 to toxic effects of ibuprofen
por: Ivshina, Irina B., et al.
Publicado: (2021)

miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
por: Lei, Chao, et al.
Publicado: (2017)

Curcumin suppresses the progression of gastric cancer by regulating circ_0056618/miR-194-5p axis
por: Li, Shan, et al.
Publicado: (2021)

Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression
por: Tang, Guojun, et al.
Publicado: (2022)

miR-302e Suppresses Glioma Progression by Targeting VEGFA
por: Xie, Yunpeng, et al.
Publicado: (2020)

Inhibition of the miR-192/215–Rab11-FIP2 axis suppresses human gastric cancer progression
por: Zhang, Xiaojing, et al.
Publicado: (2018)

MYLK and CALD1 as molecular targets in bladder cancer
por: Jin, Hui, et al.
Publicado: (2023)

Propofol suppresses the progression of non-small cell lung cancer via downregulation of the miR-21-5p/MAPK10 axis
por: Wu, Xinhua, et al.
Publicado: (2020)

Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2023)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

P1278: MEASURABLE RESIDUAL DISEASE ASSESSMENT IN THE PROSPECTIVE HAPLOMUD STUDY
por: Arnhardt, Isabell, et al.
Publicado: (2023)

Downregulation of miR-7 and miR-153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression
por: Song, Yu, et al.
Publicado: (2023)

miR-138 inhibits gastric cancer growth by suppressing SOX4
por: Pang, Lei, et al.
Publicado: (2022)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

CircITGA7 Suppresses Gastric Cancer Progression Through miR-1471/MTDH Axis
por: Jin, Haifeng, et al.
Publicado: (2021)

A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
por: Vera, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lihs74fklob77qhjblhh0cgks5